Ledger.Open graph →
SEC Form D · filed January 20, 2021

XYLOCOR THERAPEUTICS, INC

Offering
—
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Malvern, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Albert Gianchetti · Malvern, PAExec · DirectorGlenn Batchelder · Malvern, PADirectorMichael F. Powell, Ph.D · Malvern, PADirectorMike Van Meter · Irvine, CAExec · DirectorAnthony Makuch · TORONTO, Ontario, CanadaDirectorFouad Azzam, Ph.D · Malvern, PADirectorAidan F. King · Malvern, PADirectorTodd K. Rosengart, M.D · Malvern, PADirectorBenjamin Deda · Colorado Springs, CODirectorJason Rembert · Colorado Springs, COExec · DirectorFouad Azzam, Ph.D · Malvern, PADirectorAidan F. King · Malvern, PADirectorMichael F. Powell, Ph.D · Malvern, PADirectorTodd K. Rosengart, M.D · Malvern, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗